MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression

BACKGROUND: Patients with triple-negative breast cancer (TNBC) tend to develop visceral metastasis within five years, making them the most challenging BC patients to treat. The MAP7 protein family is a group of microtubule-binding proteins with a well-known role in microtubule-related cell migration...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Wen-Hung, Chu, Pei-Yi, Wang, Chen-Chi, Huang, Ping-Shen, Chan, Shih-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405500/
https://www.ncbi.nlm.nih.gov/pubmed/37550720
http://dx.doi.org/10.1186/s13062-023-00400-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405500/
https://www.ncbi.nlm.nih.gov/pubmed/37550720
http://dx.doi.org/10.1186/s13062-023-00400-x

Ejemplares similares